The
Global Protein
Assays Market, by Product Type (Reagents and Kits, Instruments), by
Technology Type (Absorbance-based Protein Assays, Colorimetric Protein Assays,
Fluorescence-based Protein Assays), by Assay Type (Dye Binding Assays,
Copper-Ion based Assays, Test Strip based Assays and Other Protein Assays) and
by End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories,
Hospitals and Academic Research Institutes) was valued at US$ 1,503.7 million
in 2016 and is projected to exhibit a CAGR of 7.6% over the forecast period
(2017–2025).
Protein
quantification is a process in protein extraction in biochemistry and molecular
biology labs that involves protein extraction, analysis, or labeling.
Quantification of protein is required for protein sample and analysis by
electrophoresis or chromatography or any other immunochemical techniques.
Commonly used protein assays are Bradford, Lowry, BCA, and UV spectroscopic
protein assays. In April 2017, Millipore Sigma launched a new Single Molecule
Counting Platform, SMCxPROTM, which is based on the principle of immunoassay
and it enables precise and sensitive detection over conventional methods.
Increasing
investments of pharmaceutical companies in protein assays is leading to
development of various drugs. Protein assays initiatives have led to new
discoveries and development of treatments tailored for specific characteristics
such as genetic makeup or genetic profile of an individual tumor that helps to
offer relatively better and effective treatment methods. In 2015, According to
a publication by Pharmaceuticals Research and Manufacturers of America (PhRMA)
— a trade group representing companies in the pharmaceutical industry in the
U.S.— the member organizations (pharmaceutical companies) of PhRMA invested
around US$ 58.8 billion on R&D, accounting for the largest of all the
biopharmaceutical R&D spending in the U.S, in 2015.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1087
Browse
29 Market Data Tables and 33 Figures spread through 180 Pages and in-depth TOC
on " Protein Assays Market, by Product Type (Reagents and Kits,
Instruments), by Technology Type (Absorbance based Protein Assays, Colorimetric
Protein Assays, Fluorescence based Protein Assays), by Assay Type (Dye Binding
Assays, Copper-Ion based Assays, Test Strip based Assays and Other Protein
Assays), by End User (Pharmaceutical and Biotechnology Companies, Clinical
Laboratories, Hospitals and Academic Research Institutes) and by Region -
Global Forecast to 2025"
Asia
Pacific market is expected to witness highest growth in the global protein
assays market over the forecast period, owing to rising application of protein
content determination in pharmacy and biotechnology. Increasing private-public
partnership for genetic analysis has aided in the market growth. Rising
biotechnology and life sciences sector in this region, as well as increasing
focus on research and development by the top market players, is another factor
for growth of the market. For instance, in January, 2016, Thermo Fisher
Scientific Inc. acquired Affymetrix to strengthen its position in biosciences
and genetic analysis as well as extend geographic reach of Affymetrix’s
products by leveraging Thermo Fisher’s market presence and infrastructure in
Asia Pacific, particularly China.
Various new biomarker identification systems and emerging new uses for
protein assays provided opportunities to the players in the global protein
assay market. For instance, in June 2017, Gyros Protein Technologies AB
launched a new version of its anti-drug antibody (ADA) solution for the immunogenicity
segment. Gyrolab ADA solution enables to automatically run drug-tolerant ADA
assays in a time efficient way reducing hands-on time, using small volumes of
patient samples and reagents, and reducing run-times. Manufacturers are likely
to focus on launching systems, which are expected to help understand protein
structures and functions, with tools to characterize post-translational
modifications, localization, and expression control including epigenetic
mechanisms. In June 2015, Thermo Fisher Scientific Inc. introduced Orbitrap
Fusion Lumos Tribrid mass spectrometer and in 2017, it launched Integrated
Ultraviolet Photo separation (UVPD) that enables specialists to perform
substantial and little atom structure assurance on a Lorentz focus (LC) time scale;
and new advanced peak determination (APD) calculation that is intended to
enhance execution of most proteomic work processes with high peptide and
protein ID rates.
Browse Research Report: https://www.coherentmarketinsights.com/market-insight/protein-assays-market-1087
Key
Takeaways of the Protein Assays Market:
The
global protein assays market is expected to exhibit a CAGR of 7.6% over the
forecast period (2017–2025). This is attributed to increasing collaborations
among pharmaceutical companies, academic researchers, regulators, and
government organizations across various regions.
Among
product type, reagents and kits segment is expected to account for the largest
share in the global protein assay market over the forecast period. This is
attributed to quick and ready-to-use modifications and the requirement of
repeat purchase of reagents.
Among
technology types, absorbance-based segment is expected to be largest
contributor in terms of revenue to the global market over the forecast period,
and this is primarily attributed to expanding effectiveness and accuracy of
absorbance-based proteins
Some
of the major players involved in global protein assays market are Thermo Fisher
Scientific Inc., GE Healthcare, Merck KGaA, Bio-Rad Laboratories, Inc., Lonza,
Abcam plc, PerkinElmer Inc., Bio-Techne, BioVision Inc., Cell Signaling
Technology, Inc., and Geno Technology Inc.
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1087
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment